Exhibit 99.1 Carter Bankshares, Inc. Announces First Quarter 2025 Financial Results Martinsville, VA, April 24, 2025 – Carter Bankshares, Inc. (the "Company") (NASDAQ:CARE), the holding company of Carter Bank (the "Bank") today announced quarterly net income of $9.0 million, or $0.39 diluted earnings per share ("EPS"), for the first quarter of 2025 compared to net income of $8.3 million, or $0.36 diluted EPS, for the fourth quarter of 2024 and net income of $5.8 million, or $0.25 diluted EPS, for the first ...

Company Overview - Carter Bankshares, Inc. (CARE) shares increased by 5% in the last trading session, closing at $15, with trading volume significantly higher than usual [1] - The stock had previously experienced a 10.2% loss over the past four weeks [1] Market Influence - The surge in Carter Bankshares stock was driven by a broader market increase, attributed to President Donald Trump's announcement of a 90-day tariff pause for non-retaliating nations, which positively impacted investor sentiment [2] Earnings Expectations - The company is projected to report quarterly earnings of $0.30 per share, reflecting a year-over-year increase of 25% [2] - Expected revenues for the upcoming report are $34.81 million, representing a 4% increase from the same quarter last year [2] Earnings Estimate Trends - The consensus EPS estimate for Carter Bankshares has remained unchanged over the last 30 days, indicating a lack of upward revisions which typically correlate with stock price movements [4] - The stock currently holds a Zacks Rank of 3 (Hold), suggesting a neutral outlook [4] Industry Context - Carter Bankshares operates within the Zacks Banks - Northeast industry, where another company, Middlefield Banc Corp. (MBCN), saw an 11.5% increase in its stock price, closing at $26.78 [4] - Middlefield Banc's consensus EPS estimate has also remained unchanged at $0.48, which is a 5.9% decrease from the previous year [5]

Core Insights - Ping An Health has integrated sustainable development into its strategy and operations, establishing a governance structure to ensure effective implementation of sustainability goals [1] - The company has achieved dual certification from WONCA, becoming the first in the world to do so in the medical health and elderly care service sector [2] - Ping An Health is leveraging advanced technology, particularly artificial intelligence, to enhance its medical service system and drive high-quality industry development [3][4] - The company has prioritized information security, obtaining multiple certifications and enhancing its security capabilities [5][6] - Ping An Health is committed to social responsibility, launching initiatives to promote health literacy and improve access to medical services [8] - The company aims to contribute to the "Healthy China" strategic goal through its CARE sustainability strategy [9] Sustainable Development - The company has established a three-level governance structure for sustainable development, ensuring effective implementation of its goals [1] - A "Sustainable Development Strategy, Goals, and Action Plan" has been created to track progress regularly [1] Certifications and Standards - In 2024, Ping An Family Doctor received dual certification from WONCA, aligning with WHO guidelines [2] - The service standards and telemedicine management communications are certified by the General Practice Branch of the Chinese Medical Association and the RACGP [2] Technological Advancements - The launch of the Ping An Medical Master model, built on hundreds of billions of parameters, enhances the company's medical services [4] - The system achieves a 99.8% Class A rate for electronic medical records and 100% accuracy in medication compliance [4] Information Security - The company obtained ISO 27001, ISO 27701, and ISO 27799 certifications, covering all business operations [5] - A domestically developed web application firewall was implemented, increasing alarm detection effectiveness by 35% [6] Social Responsibility Initiatives - The "Yilu Jianxing" health literacy promotion action reached various communities and included 40 expert-led broadcasts and 29 public welfare activities [8] - The company enhances medical service accessibility through remote healthcare options [8]

Financial Performance - Net interest income decreased by $7.9 million, or 6.4%, to $114.5 million for the year ended December 31, 2024, due to higher funding costs [225]. - The company reported net income of $24.5 million, or $1.06 diluted earnings per share for the year ended December 31, 2024, compared to net income of $23.4 million, or $1.00 diluted earnings per share for the year ended December 31, 2023 [226]. - Total noninterest income increased by $3.1 million to $21.4 million for the year ended December 31, 2024, compared to the same period in 2023 [225]. - Total noninterest expense for the year ended December 31, 2024, was $110.0 million, an increase of $4.5 million, or 4.3%, from 2023 [253]. - The provision for credit losses decreased to a recovery of $5.0 million in 2024 from a provision of $5.5 million in 2023, reflecting improved credit quality assessments [317]. - The company reported a basic earnings per common share of $1.06 for 2024, up from $1.00 in 2023, reflecting a growth of 6% [362]. - Comprehensive income for 2024 was $31,441 thousand, down from $37,561 thousand in 2023, reflecting a decrease of approximately 16.3% [363]. Loan Portfolio and Credit Quality - Total portfolio loans increased by $118.9 million, or 3.4%, primarily in the commercial real estate and construction segments during the year ended December 31, 2024 [225]. - Nonperforming loans declined by $50.2 million to $259.3 million compared to December 31, 2023, with nonperforming loans as a percentage of total portfolio loans at 7.15% [225]. - The allowance for credit losses (ACL) was $75.6 million, or 2.09% of total portfolio loans, compared to $97.1 million, or 2.77% in 2023, indicating a reduction in the ACL ratio [316]. - Net loan charge-offs increased to $16.4 million for the year ended December 31, 2024, compared to $2.3 million in 2023, with a charge-off of $15.0 million impacting the Other segment [247]. - Nonperforming loans (NPLs) decreased by $50.2 million to $259.3 million as of December 31, 2024, resulting in a NPL ratio of 7.15%, down from 8.83% in the previous year [319]. - The provision for income taxes increased by $1.0 million to $6.3 million for the year ended December 31, 2024, with an effective tax rate of 20.6% compared to 18.6% in 2023 [285]. Deposits and Funding - Total deposits increased by $431.5 million, or 11.6%, to $4.2 billion at December 31, 2024, compared to December 31, 2023 [229]. - The portfolio loans to deposit ratio was 87.3%, compared to 94.2% [225]. - Federal Home Loan Bank borrowings decreased by $323.4 million to $70.0 million at December 31, 2024, compared to $393.4 million at December 31, 2023 [229]. - Average interest-bearing deposits grew by $100.7 million, or 20.8%, while average money market accounts increased by $63.0 million, or 14.1% [321]. - The ratio of highly liquid assets to total assets was 10.9% as of December 31, 2024, down from 12.8% in 2023 [345]. Securities and Investments - The available-for-sale securities portfolio decreased by $60.6 million, now representing 15.4% of total assets compared to 17.3% [225]. - The securities portfolio comprised 43.5% variable rate securities, with 84.6% expected to reprice within the next 12 months, mitigating interest rate risk [237]. - The company purchased $10.0 million of equity securities in 2024, focusing on investments that positively impact community development [259]. - Total gross unrealized gains in the available-for-sale portfolio were $0.1 million at December 31, 2024, offset by $82.4 million of gross unrealized losses, compared to $0.7 million in gains and $92.3 million in losses at December 31, 2023 [272]. - The company may consider changes to its interest rate mix strategy if the Federal Reserve continues to reduce short-term interest rates [237]. Strategic Initiatives and Growth - The Company aims to shift from restructuring the balance sheet to pursuing a prudent growth strategy, focusing on organic growth and opportunistic acquisitions [217]. - The Company introduced new guiding principles in June 2023 to align processes and operations with its brand strategy, aiming to enhance brand awareness and support future growth [216]. - The Company has entered into a definitive purchase and assumption agreement to acquire two branch facilities in North Carolina, expected to close in the first half of 2025 [215]. - The Company has established limits on total commercial real estate balances, which should not exceed 300% of total risk-based capital, and construction loan balances should not exceed 100% of total risk-based capital [291]. Risk Management and Underwriting - The Company’s underwriting process includes multiple shock scenarios focused on cash flow and leverage to determine supportable loan amounts, enhancing risk management [290]. - Management continuously monitors delinquency trends to identify emerging patterns and potential problem loans [310]. - The economic value of equity simulation model uses rate shocks of +/- 100, 200, 300, and 400 basis points to assess the impact on the balance sheet [356]. - The CECL model estimates default probabilities driven by economic metrics, including unemployment and the Consumer Price Index, to determine expected losses [394].

Company Overview - Amgen is a biotechnology company that discovers, develops, manufactures, and delivers innovative medicines to assist patients with serious diseases [3] - The company has been a pioneer in the biotechnology industry for over 40 years and continues to leverage technology and human genetic data for innovation [3] - Amgen has a diverse pipeline aimed at treating cancer, heart disease, osteoporosis, inflammatory diseases, and rare diseases [3] Recent Recognition - In 2024, Amgen was recognized as one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes [4] - The company is included in the Dow Jones Industrial Average® and the Nasdaq-100 Index®, highlighting its status as one of the largest and most innovative non-financial companies based on market capitalization [4] Upcoming Events - Amgen will present at the 45th Annual TD Cowen Health Care Conference on March 5, 2025, with Jay Bradner, executive vice president of Research and Development, participating in a fireside chat [1] - The presentation will be available via a webcast, which will also be archived for at least 90 days post-event [2]

分组1 - Carter Bankshares, Inc. (CARE) closed at $17.74, with a 1.1% gain over the past four weeks, and a mean price target of $23 indicates a 29.7% upside potential [1] - The average price targets range from a low of $21 to a high of $24, with a standard deviation of $1.73, suggesting a potential increase of 18.4% to 35.3% from the current price level [2] - Analysts show strong agreement on CARE's ability to report better earnings, with positive trends in earnings estimate revisions indicating potential upside [4][9] 分组2 - The Zacks Consensus Estimate for CARE has increased by 4.6% due to two upward revisions in estimates over the last 30 days, with no negative revisions [10] - CARE holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [11] - While consensus price targets may not be reliable for predicting exact gains, they can provide a directional guide for price movement [12]

Core Viewpoint - Carter Bankshares, Inc. (CARE) shows potential for significant upside, with a mean price target of $23 indicating a 30.5% increase from the current price of $17.62 [1] Price Targets - The average price target consists of three estimates ranging from a low of $21 to a high of $24, with a standard deviation of $1.73, suggesting a consensus among analysts [2] - The lowest estimate indicates a 19.2% increase, while the highest suggests a 36.2% upside [2] Analyst Sentiment - Analysts exhibit strong agreement regarding CARE's ability to report better earnings than previously predicted, which supports the expectation of stock upside [4] - A positive trend in earnings estimate revisions has been shown to correlate with stock price movements, indicating potential for growth [9] Earnings Estimates - Over the last 30 days, two earnings estimates for CARE have been revised upward, with no negative revisions, leading to a 4.6% increase in the Zacks Consensus Estimate [10] - CARE holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, further indicating potential upside [11] Caution on Price Targets - While price targets are a common metric, they should not be the sole basis for investment decisions due to historical inaccuracies in predicting actual stock price movements [5][8] - Analysts may set overly optimistic price targets influenced by business relationships, which can lead to inflated expectations [6]

Here are three stocks with buy rank and strong value characteristics for investors to consider today, January 24th:Claros Mortgage Trust, Inc. (CMTG) : This real estate investment trust carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its next year earnings increasing 13.2% over the last 60 days.Claros Mortgage Trust has a price-to-earnings ratio (P/E) of 7.95, compared with 17.40 for the industry. The company possesses a Value Score  of A.ICL Group Ltd (ICL) : This specialty mine ...

Core Insights - Carter Bankshares, Inc. (CARE) reported revenue of $34.7 million for the quarter ended December 2024, marking a year-over-year increase of 13.1% [1] - The earnings per share (EPS) for the same period was $0.37, a significant improvement compared to -$0.02 a year ago [1]

Financial Performance - Q4 2024 net income was $8.3 million, or $0.36 diluted EPS, compared to a net loss of $1.9 million in Q4 2023[1] - Full year 2024 net income was $24.5 million, or $1.06 diluted EPS, compared to $23.4 million in 2023[1] - Net income for Q4 2024 was $8,280 thousand, a significant improvement from a net loss of $1,888 thousand in Q4 2023[43] - Return on average assets (QTD annualized) improved to 0.71% in Q4 2024 from -0.17% in Q4 2023[42] - Basic earnings per share for Q4 2024 were $0.36, a significant improvement from a loss of $0.08 per share in Q4 2023[43] - Adjusted net income (Non-GAAP) for the quarter ending December 2024 was $8.4 million, compared to $5.4 million in the previous quarter[50] - Adjusted earnings per common share (diluted) (Non-GAAP) for the quarter ending December 2024 was $0.37, up from $0.23 in the previous quarter[50] Loan Portfolio - Nonperforming loans decreased by $28.4 million to $259.3 million at December 31, 2024, representing 7.15% of total portfolio loans[2] - Total portfolio loans increased $29.0 million, or 3.2% annualized, to $3.6 billion at December 31, 2024[2] - The large nonperforming lending relationship represents 97.2% of total nonperforming loans and 7.0% of total portfolio loans at December 31, 2024[5] - Total portfolio loans increased by $29.0 million, or 3.2% annualized, to $3.6 billion at December 31, 2024, driven by growth in construction loans of $63.4 million and commercial real estate loans of $11.8 million[25] - Total Loans increased to $3,624,826 thousand in December 2024 from $3,505,910 thousand in December 2023[47] - Nonperforming Loans to Total Portfolio Loans decreased to 7.15% in December 2024 from 8.83% in December 2023[48] - Commercial Real Estate Loans increased to $1,869,831 thousand in December 2024 from $1,670,631 thousand in December 2023[47] - Total Nonperforming Assets decreased to $260,008 thousand in December 2024 from $311,998 thousand in December 2023[48] Deposits and Liquidity - Total deposits increased $68.4 million, or 6.7% annualized, compared to September 30, 2024[2] - Total deposits increased by $68.4 million to $4.2 billion at December 31, 2024, with interest-bearing demand accounts growing by $77.9 million[26] - Approximately 81.6% of total deposits of $4.2 billion were insured under standard FDIC insurance coverage limits at December 31, 2024[28] - Total deposits grew to $4,153,421 thousand in December 2024 from $3,721,915 thousand in December 2023[42] - Total Interest-Bearing Deposits increased to $3,495,085 thousand in December 2024 from $2,962,346 thousand in December 2023[45] - FHLB borrowings decreased by $20.0 million to $70.0 million at December 31, 2024, compared to $90.0 million at September 30, 2024[27] - The Company had $418.4 million in unpledged available-for-sale investment securities as an additional source of liquidity at December 31, 2024[31] Net Interest Income and Margin - Net interest income increased $0.4 million to $29.1 million in Q4 2024 compared to Q3 2024[11] - Net interest margin decreased one basis point to 2.58% in Q4 2024 compared to Q3 2024[11] - Net interest income for Q4 2024 was $29,148 thousand, up from $27,420 thousand in Q4 2023[43] - Net interest margin (GAAP) for Q4 2024 was 2.57%, up from 2.47% in Q4 2023[43] - Net Interest Margin (FTE) for Q4 2024 increased to 2.58% from 2.49% in Q4 2023[45] - Net interest income (FTE) for the quarter ending December 2024 was $29.3 million, slightly up from $28.9 million in the previous quarter[51] - Yield on interest-earning assets (FTE) for the quarter ending December 2024 was 4.99%, slightly down from 5.08% in the previous quarter[51] - Net Interest Income for YTD 2024 was $115,232 thousand compared to $123,314 thousand in YTD 2023[46] Efficiency and Expenses - The efficiency ratio was 83.6% for Q4 2024, compared to 80.2% in Q3 2024 and 94.8% in Q4 2023[3] - Total noninterest expense decreased by $0.2 million compared to the fourth quarter of 2023, with professional and legal fees decreasing by $0.8 million and other noninterest expenses decreasing by $0.2 million[21] - Salaries and employee benefits increased by $2.1 million, occupancy expenses increased by $1.6 million, and FDIC insurance expense increased by $1.3 million for the full year 2024 compared to 2023[23] - Adjusted efficiency ratio (Non-GAAP) for the quarter ending December 2024 improved to 82.76%, compared to 80.65% in the previous quarter[51] Credit Quality and Allowances - Allowance for credit losses decreased to $75,600 thousand in December 2024 from $97,052 thousand in December 2023[42] - Allowance for Credit Losses to Nonperforming Loans decreased to 29.15% in December 2024 from 31.35% in December 2023[48] - Allowance for credit losses decreased to $75.6 million at the end of December 2024, down from $80.9 million at the end of September 2024[49] - Total net charge-offs for the quarter ending December 2024 were $195 thousand, significantly lower than the $15.3 million in the previous quarter[49] - Net Loan Charge-offs YTD increased to $16,413 thousand in December 2024 from $2,300 thousand in December 2023[48] - Total recoveries for the quarter ending December 2024 were $175 thousand, up from $103 thousand in the previous quarter[49] Capital and Assets - Total assets increased by $45.8 million to $4.7 billion at December 31, 2024, with cash and due from banks increasing by $26.2 million to $131.2 million[24] - The Company's Tier 1 Capital ratio was 10.88% at December 31, 2024, compared to 10.83% at September 30, 2024[29] - The Company's Total Risk-Based Capital ratio was 12.13% at December 31, 2024, compared to 12.09% at September 30, 2024[30] - Total assets increased to $4,659,189 thousand as of December 31, 2024, compared to $4,512,539 thousand in December 2023[42] - Shareholders' equity increased to $384,313 thousand in December 2024 from $351,243 thousand in December 2023[42] - Total Interest-Earning Assets grew to $4,520,295 thousand in December 2024 from $4,404,458 thousand in December 2023[45] - Average earning assets for the quarter ending December 2024 increased to $4.52 billion, up from $4.45 billion in the previous quarter[51] Noninterest Income and Pre-Tax Income - Noninterest income for Q4 2024 was $5,368 thousand, compared to $3,245 thousand in Q4 2023[43] - Pre-tax pre-provision income (Non-GAAP) for the quarter ending December 2024 was $5.7 million, down from $6.8 million in the previous quarter[50] Expansion and Acquisitions - The company acquired two branches in Winston-Salem and Mooresville, North Carolina to expand its footprint[3]